Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.

November 25, 2013 — Pharmgate LLC of Ramsey, New Jersey proudly announces the approval of its flagship product, Deracin® 22% Granular Premix containing 22% chlortetracycline, by the Veterinary Drugs Directorate of Health Canada. As the majority owned US subsidiary of Jinhe Biotechnology, the largest manufacturer of chlortetracycline in the world, Pharmgate will become a significant supplier of branded chlortetracycline products in Canada.

This generic approval carries all important label claims for the drug across livestock and poultry species. Deracin 22% Granular Premix is a high quality, free flowing, and dust free granule that is manufactured and formulated in the plant that has enjoyed a 20 year history of supplying FDA compliant products.

The product is supplied in 25kg bags and will be made available to feed mills and livestock producers in the coming months. It will be marketed by Pharmgate Animal Health, Pharmgate’s marketing joint venture in North America, alongside its first product offering, Aivlosin® (tylvalosin) Water Soluble Granules, which has received considerable support from the livestock community since its launch last year.

Colin Gray, CEO of Pharmgate commented, “This is another important step in the evolution of Jinhe/Pharmgate from the largest global supplier of high quality CTC to a fully integrated and recognized animal health company. We, in company with our partners and in utilizing Pharmgate’s significant supply chain, regulatory and marketing expertise look forward to building on this success in adding future complementary products over the next several years.”

Aivlosin® is a registered trademark of ECO Animal Health Ltd.
Deracin® is a registered trademark of Pharmgate LLC.

About Pharmgate LLC
Pharmgate LLC is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., P. R. China, the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride, salinomycin and other animal health compounds. The company has marketing or supply approvals for these products in most major markets throughout the world.